Cellular immune responses against hepatitis C virus: the evidence base 2002
about
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus InfectionManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingEvidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infectionAnalysis of 'driver' and 'passenger' CD8+ T-cell responses against variable virusesViral Sequence Evolution in Acute Hepatitis C Virus InfectionCD8 Epitope Escape and Reversion in Acute HCV InfectionDivergent and convergent evolution after a common-source outbreak of hepatitis C virusCellular immune selection with hepatitis C virus persistence in humansVirus-Specific T-Cell Immunity Correlates with Control of GB Virus B Infection in MarmosetsViral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV InfectionInhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia.Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection.Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal modelsFlow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms.Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice.Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune responseWill there be a vaccine to prevent HCV infection?HCV immunology--death and the maiden T cell.Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infectionMolecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8⁺ T cells in early viral evolution.Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.Prospects for dendritic cell vaccination in persistent infection with hepatitis C virusComputational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome.Acute hepatitis C in a chronically HIV-infected patient: evolution of different viral genomic regionsComparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNACytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C.High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infectionComprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses.Adaptive immunity to the hepatitis C virus.Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture ModelCross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection.
P2860
Q27473001-C3DDFC31-8BD9-4312-BEE4-2D313061F5B1Q27477614-6DCF7216-A181-4EFB-9F79-B87A921FE70DQ27477626-0D7FB3F7-3E5D-4B49-B6CC-09B2EC420B43Q27478105-DC9E5CC0-12CB-4A06-8866-F365E10EB301Q27478133-90D12324-912F-4C96-8119-2318A0C59061Q27484985-4BF2BF05-3F7B-4C4C-A5C9-1614C744517BQ27485189-7E6D50F3-9AAF-47B1-B90A-4954D36A8E76Q27485216-EDE99DED-ADCF-40BF-9D86-F26288DD1B13Q27485219-027D5C83-2500-46A4-8728-62E552A25697Q27485455-9C69FDFF-B743-4636-94CA-0F278FADFF03Q27487395-9CE3EAED-08D2-435D-82C1-F6CB3877A159Q30767073-560C90EC-AE36-4C94-B81D-0910FEF17BBEQ31112300-8270BA5D-BA53-4F26-A582-A7941FD37127Q33282312-FBF5C624-C4F6-4FF3-AD1D-D225BC5AC274Q33363196-EA4530B8-F167-4EBD-8AA9-BE44A1AE2602Q33521313-1A281326-9D95-4D77-931F-B6064C7F1059Q33826033-F256AD23-9C38-42C2-84EB-5661348B7034Q33867634-61960490-2315-4CCD-AFD1-44C05F72A072Q33868156-548FCBE0-88FB-40B0-9435-F4BCD6BF1908Q33955998-6CBF1C48-BD98-48A8-AE75-C8B21040BB86Q34546149-B3F2E0E4-79D7-4397-B838-A9A3A2BC1792Q34552781-2BE3B69E-282A-4BF2-B5D0-CBB87C721322Q34781537-2F44F28E-73B7-424F-9462-E41F8D967C5BQ35091469-0AD86BBF-F949-40EE-8C9D-5C50ED9D47DFQ35214136-613DF32C-8A10-4BAC-837A-C2FF6BA35C17Q35249393-2954E263-9092-49DD-A9E9-A4EF75ED69D9Q35531150-EA54B470-CBF1-4DF2-99C2-B10EACB143C5Q35673342-113B009D-C85E-4077-8910-BB26BE70AA2AQ35784239-A854BD18-E494-4A11-8CD9-33F30E1F3BA4Q35943481-B06E914C-03E4-431B-98FF-D36CCBF66E42Q36190673-4764894F-2751-4B82-AB58-D1062D71A0E8Q36280098-E87CED8D-E317-4C34-BC8C-07BF4D3094CFQ36373301-AA78897A-1778-4C6C-802F-ABA0070193B2Q36978998-A3D18B1B-6AEE-489B-B207-51B3BB968D68Q37282559-6918A359-191B-40A6-93F1-C4B9FA10932AQ37381208-506C0F9C-3019-4065-80A6-F8EDF75585F0Q37696017-978E1402-0F45-4128-ABAF-67BE33722757Q37805839-000635CE-9D3A-4EB8-B450-6D3EAAAD7A5FQ38713042-8FA2159E-7B7A-4DC4-B544-8A5126886D22Q39024688-95E16D5A-0AF0-4428-AC34-286B5489123C
P2860
Cellular immune responses against hepatitis C virus: the evidence base 2002
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cellular immune responses against hepatitis C virus: the evidence base 2002
@ast
Cellular immune responses against hepatitis C virus: the evidence base 2002
@en
Cellular immune responses against hepatitis C virus: the evidence base 2002
@nl
type
label
Cellular immune responses against hepatitis C virus: the evidence base 2002
@ast
Cellular immune responses against hepatitis C virus: the evidence base 2002
@en
Cellular immune responses against hepatitis C virus: the evidence base 2002
@nl
prefLabel
Cellular immune responses against hepatitis C virus: the evidence base 2002
@ast
Cellular immune responses against hepatitis C virus: the evidence base 2002
@en
Cellular immune responses against hepatitis C virus: the evidence base 2002
@nl
P2093
P2860
P1476
Cellular immune responses against hepatitis C virus: the evidence base 2002
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.2002.01840.X
P577
2002-05-01T00:00:00Z